Totally implantable venous access port systems for patients receiving chemotherapy for gynaecological or breast malignancies: A prospective clinical trial examining the safety, ef…

Background: Due to the increasing use of chemotherapy, supportive drugs (i.e. bisphosphonates) or long term antibody treatment (i.e. trastuzumab) secure intravenous access is becoming increasingly important. One method is to implant a central venous access port device (CVAPD). While a CVAPD appears to be secure and practicable, few studies have investigated patients’ quality of life in relation to the devices. The aim of this study was to analyze patients’ port-related quality of life. Methods: A prospective cohort of a total of 260 consecutive patients with gynecological or breast malignancies were asked to tak…